Evidence map›Paper›PMID 30609804›Full record

ArticleInternational journal of molecular sciences2019

In Vitro Induction of Tendon-Specific Markers in Tendon Cells, Adipose- and Bone Marrow-Derived Stem Cells is Dependent on TGFβ3, BMP-12 and Ascorbic Acid Stimulation.

Carlotta Perucca Orfei, Marco Viganò, John R Pearson, Alessandra Colombini, Paola De Luca, Enrico Ragni, Leonor Santos-Ruiz, Laura de Girolamo

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Mechanobiological Strategies to Enhance Ovine (Animals : an open access journal from MDPI · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Directing iPSC differentiation into iTenocytes using combined scleraxis overexpression and cyclic loading.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  10. Article
  11. Review
  12. Growth factors in the treatment of Achilles tendon injury.Frontiers in bioengineering and biotechnology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Advances in Stem Cell Therapies for Rotator Cuff Injuries.Frontiers in bioengineering and biotechnology · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Carlotta Perucca OrfeiIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. carlotta.perucca@gmail.com.
Marco ViganòIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. marco.vigano@grupposandonato.it.ORCID 0000-0002-6463-6564
John R PearsonAndalusian Centre for Nanomedicine and Biotechnology, BIONAND, 29590 Málaga, Spain. jrpearson@bionand.es.ORCID 0000-0002-2267-0844
Alessandra ColombiniIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. alessandra.colombini@grupposandonato.it.ORCID 0000-0002-1800-3424
Paola De LucaIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. deluca.paola@grupposandonato.it.
Enrico RagniIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. enrico.ragni@grupposandonato.it.
Leonor Santos-RuizAndalusian Centre for Nanomedicine and Biotechnology, BIONAND, 29590 Málaga, Spain. lsantos@uma.es.ORCID 0000-0001-6159-6045
Laura de GirolamoIRCCS Istituto Ortopedico Galeazzi, Orthopaedic Biotechnology Lab, 20161 Milan, Italy. laura.degirolamo@grupposandonato.it.
Istituto Ortopedico Galeazzi · ITAndalusian Centre for Nanomedicine and Biotechnology · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mesenchymal Stem Cells (MSCs) and tissue-specific progenitors have been proposed as useful tools for regenerative medicine approaches in bone, cartilage and tendon-related pathologies. The differentiation of cells towards the desired, target tissue-specific lineage has demonstrated advantages in the application of cell therapies and tissue engineering. Unlike osteogenic and chondrogenic differentiation, there is no consensus on the best tenogenic induction protocol. Many growth factors have been proposed for this purpose, including BMP-12, b-FGF, TGF-β3, CTGF, IGF-1 and ascorbic acid (AA). In this study, different combinations of these growth factors have been tested in the context of a two-step differentiation protocol, in order to define their contribution to the induction and maintenance of tendon marker expression in adipose tissue and bone marrow derived MSCs and tendon cells (TCs), respectively. Our results demonstrate that TGF-β3 is the main inducer of scleraxis, an early expressed tendon marker, while at the same time inhibiting tendon markers normally expressed later, such as decorin. In contrast, we find that decorin is induced by BMP-12, b-FGF and AA. Our results provide new insights into the effect of different factors on the tenogenic induction of MSCs and TCs, highlighting the importance of differential timing in TGF-β3 stimulation.

Indexed as

Adipose TissueAscorbic AcidBasic Helix-Loop-Helix ProteinsBiomarkersBone Marrow CellsBone Morphogenetic ProteinsCell DifferentiationCells, CulturedCollagen Type ICollagen Type I, alpha 1 ChainCulture MediaDecorinFemaleHomeodomain ProteinsHumansMaleAscorbic AcidBasic Helix-Loop-Helix ProteinsBiomarkersBone Morphogenetic ProteinsCollagen Type ICollagen Type I, alpha 1 ChainCulture MediaDecorinHomeodomain ProteinsMKX protein, humanSCX protein, humanTransforming Growth Factor beta3adipose-derived MSCsascorbic acidBMP-12Bone marrow-derived MSCsFGFtendon cellstenogenic differentiationTGFbeta

Identifiers

PMID30609804
PMCPMC6337430
OpenAlexW2907477078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.